Literature DB >> 1778911

Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea.

O Taguchi1, Y Kikuchi, W Hida, N Iwase, M Satoh, T Chonan, T Takishima.   

Abstract

To determine whether the intensity of dyspnea at a given level of respiratory motor output differs between bronchoconstriction and the presence of an external resistance, we compared the sensation of difficulty in breathing during isocapnic voluntary hyperventilation in six normal subjects. An external resistance of 1.9 cmH2O.1-1.s was applied during both inspiration and expiration. To induce bronchoconstriction, histamine aerosol (5 mg/ml) was inhaled until airway resistance (Raw) increased to a level approximately equal to the subject's control Raw plus the added external resistance. To clarify the role of vagal afferents on the genesis of dyspnea during both forms of obstruction to airflow, the effect of airway anesthesia by lidocaine aerosol inhalation was also examined after histamine and during external resistive loading. The sensation of difficulty in breathing was rated at 30-s intervals on a visual analog scale during isocapnic voluntary hyperpnea, in which the subjects were asked to copy an oscilloscope volume trace obtained previously during progressive hypercapnia. Histamine inhalation significantly increased the intensity of the dyspneic sensation over the equivalent external resistive load at the same levels of ventilation and occlusion pressure during voluntary hyperpnea. Inhaled lidocaine decreased the sensation of dyspnea during bronchoconstriction with no change in Raw, but it did not significantly change the sensation during external resistive loading. These results suggest that afferent vagal activity plays a role in the genesis of dyspnea during bronchoconstriction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1778911     DOI: 10.1152/jappl.1991.71.6.2183

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  16 in total

Review 1.  [Acute dyspnoea].

Authors:  U Wagner; C Vogelmeier
Journal:  Internist (Berl)       Date:  2005-09       Impact factor: 0.743

2.  Asthma-like symptoms induced by the methacholine challenge test: do they predict a negative-to-positive switch in the test result?-case report.

Authors:  Abraham B Bohadana; Ariel Rokach; Pascal Wild; Gabriel Izbicki
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

3.  Reliability and predictors of resistive load detection in children with persistent asthma: a multivariate approach.

Authors:  Andrew Harver; Allison Dyer; Jennifer L Ersek; Harry Kotses; C Thomas Humphries
Journal:  J Asthma       Date:  2014-09-17       Impact factor: 2.515

Review 4.  Vagal Afferent Innervation of the Airways in Health and Disease.

Authors:  Stuart B Mazzone; Bradley J Undem
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

5.  Effects of feedback on the perception of inspiratory resistance in children with persistent asthma: a signal detection approach.

Authors:  Andrew Harver; Harry Kotses; Jennifer Ersek; Charles Thomas Humphries; William S Ashe; Hugh R Black
Journal:  Psychosom Med       Date:  2013-09-27       Impact factor: 4.312

Review 6.  The role of nerves in asthma.

Authors:  Bradley J Undem; Michael J Carr
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

Review 7.  [Heart and lungs : cardinal symptom dyspnea].

Authors:  M O Henke; C F Vogelmeier
Journal:  Herz       Date:  2013-05       Impact factor: 1.443

8.  [Differential diagnoses of dyspnoea].

Authors:  A R Koczulla; C Vogelmeier
Journal:  Internist (Berl)       Date:  2007-12       Impact factor: 0.743

9.  Respiratory symptom perception differs in obese women with strong or mild breathlessness during constant-load exercise.

Authors:  Vipa Bernhardt; Tony G Babb
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

Review 10.  The symptomatic relief of dyspnea.

Authors:  Giovanni Elia; Jay Thomas
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.